Ying Du
Chief Executive Officer en ZAI LAB LIMITED .
Fortuna: 2 M $ al 31/03/2024
Perfil
Fundador de Zai Lab Ltd., Hutchison MediPharma Ltd. y Zai Venture Partners, Ying Du es un empresario que ocupa el cargo de presidente y director general de Zai Lab Ltd. y socio general de Zai Venture Partners (una filial de Zai Lab Ltd.). El Dr. Du también forma parte del consejo de administración de Eden Biologics, Inc. En el pasado, el Dr. Du ocupó los cargos de Director General de Hutchison MediPharma Ltd., Director Científico de Hutchison China MediTech Ltd., Vicepresidente Ejecutivo de Inversiones Sanitarias de Hutchison Whampoa (China) Ltd. y Socio de Riesgo de Sequoia Capital China Advisors (Hong Kong) Ltd. Ying Du se doctoró en la Universidad de Cincinnati (Ohio) y se licenció en la Universidad de Jilin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZAI LAB LTD.
0.11% | 03/04/2024 | 1 107 972 ( 0.11% ) | 2 M $ | 31/03/2024 |
Cargos activos de Ying Du
| Empresas | Cargo | Inicio |
|---|---|---|
| ZAI LAB LIMITED | Chief Executive Officer | 01/04/2014 |
| JHL BIOTECH, INC. | Director/Board Member | 17/12/2012 |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Founder | 01/01/2017 |
Antiguos cargos conocidos de Ying Du.
| Empresas | Cargo | Fin |
|---|---|---|
Hongshan
 Hongshan Investment ManagersFinance Sequoia Capital China Advisors (Hong Kong) Ltd. (SCCA-HK) is a venture capital investment firm based in Hong Kong. They are a subsidiary of Sequoia Capital Operations LLC, headquartered in Menlo Park, California. The parent firm was founded in 1972 by Donald T. Valentine. The Hong Kong office was established in 2005. Sequoia Capital has additional offices in Shanghai, Beijing, Bangalore, Mumbai and Israel. SCCA-HK caters to both the founders and the management of unlisted firms in their capacity of partner or limited partner. The firm's investors are typically educational and philanthropic institutions. | Private Equity Investor | - |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Corporate Officer/Principal | - |
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
Formación de Ying Du.
| University of Cincinnati (Ohio) | Doctorate Degree |
| Jilin University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Empresas privadas | 5 |
|---|---|
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Finance |
Hongshan
Hongshan Investment ManagersFinance Sequoia Capital China Advisors (Hong Kong) Ltd. (SCCA-HK) is a venture capital investment firm based in Hong Kong. They are a subsidiary of Sequoia Capital Operations LLC, headquartered in Menlo Park, California. The parent firm was founded in 1972 by Donald T. Valentine. The Hong Kong office was established in 2005. Sequoia Capital has additional offices in Shanghai, Beijing, Bangalore, Mumbai and Israel. SCCA-HK caters to both the founders and the management of unlisted firms in their capacity of partner or limited partner. The firm's investors are typically educational and philanthropic institutions. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Finance |
- Bolsa de valores
- Insiders
- Ying Du
